A Double-Blind, Randomised, Crossover Trial of Two Botulinum Toxin Type A in Patients with Spasticity

BACKGROUND: Botulinum toxin type A (btxA) is one of the main treatment choices for patients with spasticity. Prosigne® a new released botulinum toxin serotype A may have the same effectiveness as Botox® in focal dystonia. However, there are no randomized clinical trials comparing these formulations...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarany, Fábio Coelho, Picon, Paulo Dornelles, Guarany, Nicole Ruas, dos Santos, Antonio Cardoso, Chiella, Bianca Paula Mentz, Barone, Carolina Rocha, Fendt, Lúcia Costa Cabral, Schestatsky, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585303/
https://www.ncbi.nlm.nih.gov/pubmed/23468866
http://dx.doi.org/10.1371/journal.pone.0056479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585303/
https://www.ncbi.nlm.nih.gov/pubmed/23468866
http://dx.doi.org/10.1371/journal.pone.0056479

Ejemplares similares